Ignite Creation Date:
2024-05-05 @ 4:35 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00274781
Status:
COMPLETED
Last Update Posted:
2015-07-10
First Post:
2006-01-10
Brief Title:
Arsenic Trioxide and Gemtuzumab Ozogamicin in Treating Patients With Advanced Myelodysplastic Syndromes
Sponsor:
The Cleveland Clinic
Organization:
The Cleveland Clinic
Organization Data
Organization:
The Cleveland Clinic
Class:
OTHER
Study ID:
CCF6818
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
The Cleveland Clinic
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |
| University of Michigan | OTHER |